Magenta Therapeutics (MGTA) Desperately Considers All Its Options
Wasim Omar
February 3, 2023
Magenta Therapeutics Inc. (NASDAQ: MGTA) is facing a lethal uphill battle in its fight for survival. This biopharma company saw its prospects flatten after dismal